View Full Company Profile

CBAK Energy Technology, Inc.

CIK: 1117171 Filed: March 31, 2026 10-K

Key Highlights

  • Vertically integrated model through subsidiary Hitrans to reduce production costs by 15–20%.
  • Rapid production scaling at Nanjing facility and modernization of Dalian factory.
  • Strategic pivot toward high-capacity EV cells and emerging sodium-ion battery technology.

Financial Analysis

CBAK Energy Technology, Inc. Annual Report - How They Did This Year

I’ve put together this guide to help you understand CBAK Energy Technology’s performance. My goal is to break down their complex financial filings into simple terms so you can decide if this company fits your investment goals.

1. What does this company do?

CBAK is a Chinese manufacturer of lithium-ion batteries. They make power cells for electric vehicles (EVs), e-bikes, and large energy storage systems. They use a "vertically integrated" model, meaning they own their supply chain. Through their subsidiary, Hitrans, they produce cathode materials—the most expensive part of a battery. By making these parts themselves, they aim to keep more profit instead of paying outside suppliers.

2. Financial performance

It was a rocky year for the company’s bottom line. Revenue grew 10.5%, reaching $195.2 million compared to $176.6 million in 2024. However, profitability collapsed. The company went from a $9.6 million profit in 2024 to a $10.4 million loss in 2025. This happened because of high spending on equipment, rising material costs, and intense price wars in the Chinese market.

3. Major wins and challenges

  • Wins: The company is growing quickly. They ramped up production at their Nanjing facility and are updating their older Dalian factory to make modern, high-demand batteries. Their investment in Hitrans aims to lower the cost of making batteries by 15–20% once fully operational.
  • Challenges: Auditors have expressed "substantial doubt" about the company’s ability to stay in business due to high debt and a lack of cash. Additionally, the company reported "material weaknesses" in their financial reporting, citing a lack of qualified accounting staff, which increases the risk of future accounting errors.

4. Financial health: The "Cash Flow" hurdle

CBAK is a U.S.-listed company that operates entirely in China. This creates a "locked cash" risk:

  • No Dividends: The company has never paid a dividend and has a history of losses, so they cannot pay shareholders. They are currently reinvesting all available cash into new equipment.
  • Regulatory Walls: Strict Chinese currency regulations make it difficult to move money from their Chinese subsidiaries to the U.S. parent company. This limits their ability to pay off U.S. debt or return money to international investors.

5. Key risks: The "China Factor"

  • Legal Uncertainty: Because the company operates in China, U.S. investors have little legal protection if things go wrong.
  • Government Oversight: Under U.S. law, if regulators cannot inspect the company’s auditors in China, the stock could be removed from U.S. exchanges.
  • Operational Risks: Three customers account for 42% of their revenue. Since these customers don't have long-term contracts, the company’s income could drop suddenly if these clients leave.

6. Competitive positioning

CBAK is moving away from older, low-profit batteries toward high-capacity cells for EVs. They are also investing in sodium-ion batteries. These are cheaper to make and work better in cold weather, offering a strategic alternative to lithium.

7. Future outlook

The company is in a high-stakes growth phase. Management hopes that new battery technology and owning their supply chain will create a competitive advantage. However, their survival depends on raising more money to cover their losses and expansion costs.


Investor Takeaway: This is a speculative play. The company is betting heavily on future technology to turn its financial ship around, but the combination of "substantial doubt" from auditors, accounting weaknesses, and the inability to easily move cash out of China makes this a high-risk investment. Before considering a position, ask yourself if you are comfortable with the possibility that the company may need to raise significant capital—which could dilute your shares—just to keep operations running.

Risk Factors

  • Auditors expressed substantial doubt regarding the company's ability to continue as a going concern.
  • Material weaknesses in financial reporting due to a lack of qualified accounting staff.
  • High concentration risk with three customers accounting for 42% of total revenue.
  • Regulatory and currency restrictions in China limiting capital mobility to U.S. investors.

Why This Matters

Stockadora is highlighting CBAK because it represents a classic 'high-risk, high-reward' inflection point. While the company is successfully scaling its production and vertical integration, the combination of auditor 'going concern' warnings and material accounting weaknesses creates a volatile environment for investors.

We surfaced this report because the company’s reliance on a small customer base and the 'locked cash' reality of Chinese operations make it a critical case study in the dangers of cross-border investing. It serves as a reminder to look past top-line growth to the underlying financial health and regulatory stability of U.S.-listed Chinese firms.

Financial Metrics

Revenue (2025) $195.2 million
Net Income (2025) -$10.4 million
Revenue Growth 10.5%
Profitability Shift From $9.6 million profit to $10.4 million loss
Customer Concentration 42% of revenue from three clients

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

April 2, 2026 at 12:11 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.